Literature DB >> 16542840

Parkinsonism and midbrain dysfunction after shunt placement for obstructive hydrocephalus.

Shoji Yomo1, Kazuhiro Hongo, Takayuki Kuroyanagi, Shigeaki Kobayashi.   

Abstract

We report a patient in whom placement of a ventriculoperitoneal shunt for obstructive hydrocephalus secondary to non-neoplastic aqueductal stenosis was complicated by progressive parkinsonism and midbrain dysfunction. These sequelae were refractory to treatment, including shunt revision and levodopa therapy. These findings contradict the opinion from the literature that this type of parkinsonism is a reversible condition and levodopa therapy is effective for managing the symptoms. We discuss the pathophysiological mechanism of this complication.

Entities:  

Mesh:

Year:  2006        PMID: 16542840     DOI: 10.1016/j.jocn.2005.04.023

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Successful treatment of tremor by endoscopic third ventriculostomy in an adolescent with obstructive hydrocephalus due to tectal glioma: case report.

Authors:  Shih-Hung Yang; Abhaya V Kulkarni
Journal:  Childs Nerv Syst       Date:  2011-03-03       Impact factor: 1.475

2.  Cerebrospinal fluid shunt-induced chorea: case report and review of the literature on shunt-related movement disorders.

Authors:  Claudio M de Gusmäo; Aaron L Berkowitz; Albert Y Hung; M Brandon Westover
Journal:  Pract Neurol       Date:  2014-07-04

3.  Parkinsonism secondary to ventriculoperitoneal shunt in a patient with hydrocephalus.

Authors:  André Corsino da Costa; Nilson Pinheiro Júnior; Clecio Godeiro Junior; Ana Clara Aragão Fernandes; Cítara Trindade de Queiroz; Anaís Concepcion Marinho Andrade de Moura; Carlos Eduardo França de Aquino; Marianne de Araújo Rego
Journal:  Surg Neurol Int       Date:  2021-08-30

4.  Secondary parkinsonism induced by hydrocephalus after subarachnoid and intraventricular hemorrhage.

Authors:  Min Cheol Chang; Min Ho Chun
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.